Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Horn

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Analysis of purported erythromycin-warfarin interactionJohn R Horn
Archives of Internal Medicine|April 13, 2011
Hard-stops for drug interactionsJohn R Horn
Journal of Managed Care Pharmacy : JMCP|November 5, 2011
Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessaryJohn R Horn, Philip D Hansten
The Annals of Pharmacotherapy|June 16, 2011
Comment: evaluation of contraindicated drug-drug interaction alerts in a hospital settingJohn R Horn, Philip D Hansten
Journal of the American Pharmacists Association : Japha|May 24, 2012
OTC polyethylene glycol 3350 and pharmacists' role in managing constipationJohn R Horn, Maria Marzella Mantione, John F Johanson
The Annals of Pharmacotherapy|March 29, 2007
Proposal for a new tool to evaluate drug interaction casesJohn R Horn, Philip D Hansten, Lingtak-Neander Chan
Clinical Drug Investigation|March 13, 2021
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug InteractionsMatthew P Rutman, John R Horn, Diane K Newman, et al.
The Annals of Pharmacotherapy|October 4, 2012
Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening softwareRichard D Boyce, Carol Collins, Marc Clayton, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2017
Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing AnticonvulsantsNathan P Clark, Kim Hoang, Thomas Delate, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 5, 2011
Customizing clinical decision support to prevent excessive drug-drug interaction alertsJohn R Horn, Philip D Hansten, Jacqueline D Osborn, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Analysis of purported erythromycin-warfarin interactionJohn R Horn
Archives of Internal Medicine|April 13, 2011
Hard-stops for drug interactionsJohn R Horn
Journal of Managed Care Pharmacy : JMCP|November 5, 2011
Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessaryJohn R Horn, Philip D Hansten
The Annals of Pharmacotherapy|June 16, 2011
Comment: evaluation of contraindicated drug-drug interaction alerts in a hospital settingJohn R Horn, Philip D Hansten
Journal of the American Pharmacists Association : Japha|May 24, 2012
OTC polyethylene glycol 3350 and pharmacists' role in managing constipationJohn R Horn, Maria Marzella Mantione, John F Johanson
The Annals of Pharmacotherapy|March 29, 2007
Proposal for a new tool to evaluate drug interaction casesJohn R Horn, Philip D Hansten, Lingtak-Neander Chan
Clinical Drug Investigation|March 13, 2021
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug InteractionsMatthew P Rutman, John R Horn, Diane K Newman, et al.
The Annals of Pharmacotherapy|October 4, 2012
Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening softwareRichard D Boyce, Carol Collins, Marc Clayton, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2017
Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing AnticonvulsantsNathan P Clark, Kim Hoang, Thomas Delate, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 5, 2011
Customizing clinical decision support to prevent excessive drug-drug interaction alertsJohn R Horn, Philip D Hansten, Jacqueline D Osborn, et al.
Pageof 4